TY - JOUR
T1 - Using primary care data to understand opioid prescribing, policy impacts and clinical outcomes
T2 - A protocol for the OPPICO study
AU - Cangadis-Douglass, Helena
AU - Jung, Monica
AU - Xia, Ting
AU - Buchbinder, Rachelle
AU - Lalic, Samanta
AU - Russell, Grant
AU - Andrew, Nadine
AU - Pearce, Christopher
AU - Bell, J. Simon
AU - Ilomäki, Jenni
AU - Nielsen, Suzanne
N1 - Funding Information:
This work was supported by an NHMRC Ideas Grant # 2002193 . SN is the recipient of an NHMRC Research Fellowship # 1163961 . RB is supported by a NHMRC Investigator Leadership (L3) Fellowship # APP1194483 . JSB is supported by a NHMRC Dementia Leadership Fellowship #1140298. MJ and HCD are recipients of PhD Scholarships from the Monash Addiction Research Centre.
Funding Information:
This work was supported by an NHMRC Ideas Grant #2002193. SN is the recipient of an NHMRC Research Fellowship #1163961. RB is supported by a NHMRC Investigator Leadership (L3) Fellowship #APP1194483. JSB is supported by a NHMRC Dementia Leadership Fellowship #1140298. MJ and HCD are recipients of PhD Scholarships from the Monash Addiction Research Centre.SN has received untied research funding to study opioid harms from Seqirus and is a named investigator on an implementation study of buprenorphine depot funded by Indivior. JSB has received grant funding or consulting funds from the National Health and Medical Research Council (NHMRC), Medical Research Future Fund (MRFF), Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organisations all unrelated to this work. All grants and consulting funds were paid to the employing institution.
Funding Information:
SN has received untied research funding to study opioid harms from Seqirus and is a named investigator on an implementation study of buprenorphine depot funded by Indivior. JSB has received grant funding or consulting funds from the National Health and Medical Research Council (NHMRC) , Medical Research Future Fund (MRFF) , Victorian Government Department of Health and Human Services , Dementia Australia Research Foundation , Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organisations all unrelated to this work. All grants and consulting funds were paid to the employing institution.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/12
Y1 - 2022/12
N2 - Introduction: Prescription opioid use in Australia has increased over the last 3 decades. The majority of opioids are prescribed and dispensed in primary care, however, there are few studies that are specific to opioid prescribing in this setting. Evidence about the impact of key government policy strategies to optimize opioid prescribing in primary care is limited. The aim of this study is to examine the impact of recent policy changes and clinical guidelines on opioid prescribing in primary care. Methods and analysis: Longitudinal analysis of people prescribed opioid analgesics using Population Level Analysis and Reporting (POLAR) data. POLAR is a primary care dataset comprising 464 primary health care practices in Victoria, Australia. People prescribed opioid analgesics between 2015 and 2020 will be included. The impact of opioid policies and guideline recommendations will be evaluated using interrupted time series models. Group- based trajectory modelling and multivariate regression will be used to identify patterns of opioid cessation and the provision of corresponding non-opioid interventions. Ethics and dissemination: The study has received Monash University Human Research Ethics Committee approval (ID 24139). Permission to access, collate and use POLAR data is granted from Outcome Health as the data custodians. The results of this study will be disseminated through publication in international journals, presented at national and international scientific conferences, and disseminated to consumers, policy makers, primary care providers and primary health networks. Protocol registration details: EU PAS Register (EUPAS43218)
AB - Introduction: Prescription opioid use in Australia has increased over the last 3 decades. The majority of opioids are prescribed and dispensed in primary care, however, there are few studies that are specific to opioid prescribing in this setting. Evidence about the impact of key government policy strategies to optimize opioid prescribing in primary care is limited. The aim of this study is to examine the impact of recent policy changes and clinical guidelines on opioid prescribing in primary care. Methods and analysis: Longitudinal analysis of people prescribed opioid analgesics using Population Level Analysis and Reporting (POLAR) data. POLAR is a primary care dataset comprising 464 primary health care practices in Victoria, Australia. People prescribed opioid analgesics between 2015 and 2020 will be included. The impact of opioid policies and guideline recommendations will be evaluated using interrupted time series models. Group- based trajectory modelling and multivariate regression will be used to identify patterns of opioid cessation and the provision of corresponding non-opioid interventions. Ethics and dissemination: The study has received Monash University Human Research Ethics Committee approval (ID 24139). Permission to access, collate and use POLAR data is granted from Outcome Health as the data custodians. The results of this study will be disseminated through publication in international journals, presented at national and international scientific conferences, and disseminated to consumers, policy makers, primary care providers and primary health networks. Protocol registration details: EU PAS Register (EUPAS43218)
KW - Australia
KW - General practice
KW - Migraine
KW - Musculoskeletal conditions
KW - Opioid
KW - Policy
KW - Primary care
KW - Protocol
UR - http://www.scopus.com/inward/record.url?scp=85135806628&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2022.07.041
DO - 10.1016/j.sapharm.2022.07.041
M3 - Article
C2 - 35963765
AN - SCOPUS:85135806628
SN - 1551-7411
VL - 18
SP - 4129
EP - 4137
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
IS - 12
ER -